CD44 and breast cancer: Duru et al. pointed out that the SOX2/OCT4/lincRNA-ROR signaling axis is upregulated in aggressive clones from the CD49f+/CD44+/CD24− MCF10DCIS stem cell population to regulate self-renewal of CSCs in BC [205].